Literature DB >> 2145065

Inhibition of experimental metastasis of murine Lewis lung carcinoma by an inhibitor of glucosylceramide synthase and its possible mechanism of action.

J Inokuchi1, M Jimbo, K Momosaki, H Shimeno, A Nagamatsu, N S Radin.   

Abstract

In view of the increasing evidence that glucosphingolipids (GSLs) on tumor cell surfaces play an important role in tumor metastasis, an inhibitor of glucosylceramide synthase, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (D-PDMP) was used to evaluate the role of GSLs in this respect. Treatment of Lewis lung carcinoma cells with 5 microM D-PDMP resulted in a time-dependent marked decrease in levels of all cellular GSLs (glucosylceramide, lactosylceramide, ceramide trihexoside, globoside, and ganglioside GM3). By 6 days, the total GSL content was reduced to approximately 20% of the level in the untreated control cells and at the same time the lung-colonizing capacity of the PDMP-treated cells in inoculated mice was greatly reduced. Closely associated with the degree of GSL depletion, the ability of the cells to invade reconstituted basement membranes in vitro was also reduced, suggesting that GSLs in tumor cell membranes modulate the cell surface interaction with basement membrane components. In order to assess a possible contribution of the defective capacities to drug-induced suppression of experimental metastasis and invasion, we tested the effect of D-PDMP on attachment and migration to laminin and fibronectin and found that the inhibitor specifically reduced the laminin-mediated attachment and migration, whereas it had no effect on fibronectin-mediated attachment and migration. These effects of the inhibitor on lung colonizing capacity in vivo and the invasion, adhesion, and migration properties of the cells in vitro were reversible within 24 h after removal of the drug. By contrast, L-PDMP (the enantiomeric form of D-PDMP), which has no inhibitory activity on glucosylceramide synthesis, did not cause any of the changes produced by D-PDMP. Together, these results suggest that GSLs in tumor cell membranes are essential for the metastatic spread of tumor cells through basement membranes, modulating the interaction of laminin and its receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2145065

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

1.  Targeting glucosylceramide synthase sensitizes imatinib-resistant chronic myeloid leukemia cells via endogenous ceramide accumulation.

Authors:  Yusuf Baran; Jacek Bielawski; Ufuk Gunduz; Besim Ogretmen
Journal:  J Cancer Res Clin Oncol       Date:  2011-08-11       Impact factor: 4.553

2.  3'-Azidothymidine significantly alters glycosphingolipid synthesis in melanoma cells and decreases the shedding of gangliosides.

Authors:  R Steet; M Alizadeh; P Melançon; R D Kuchta
Journal:  Glycoconj J       Date:  1999-03       Impact factor: 2.916

3.  Studies of the action of ceramide-like substances (D- and L-PDMP) on sphingolipid glycosyltransferases and purified lactosylceramide synthase.

Authors:  S Chatterjee; T Cleveland; W Y Shi; J Inokuchi; N S Radin
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

4.  Ceramide glycosylation by glucosylceramide synthase selectively maintains the properties of breast cancer stem cells.

Authors:  Vineet Gupta; Kaustubh N Bhinge; Salman B Hosain; Katherine Xiong; Xin Gu; Runhua Shi; Ming-Yi Ho; Kay-Hooi Khoo; Su-Chen Li; Yu-Teh Li; Suresh V Ambudkar; S Michal Jazwinski; Yong-Yu Liu
Journal:  J Biol Chem       Date:  2012-08-30       Impact factor: 5.157

5.  Differential effects of synthetic sphingosine derivatives on melanoma cell motility, growth, adhesion and invasion in vitro.

Authors:  C Helige; J Smolle; R Fink-Puches; R Hofmann-Wellenhof; E Hartmann; T Bär; R R Schmidt; H A Tritthart
Journal:  Clin Exp Metastasis       Date:  1996-11       Impact factor: 5.150

Review 6.  Current and future strategies to block tumor angiogenesis, invasion, and metastasis.

Authors:  P J Effert; G Gastl; T Strohmeyer
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

Review 7.  Killing tumours by ceramide-induced apoptosis: a critique of available drugs.

Authors:  Norman S Radin
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

Review 8.  Lung cancer and lung injury: the dual role of ceramide.

Authors:  Tzipora Goldkorn; Samuel Chung; Simone Filosto
Journal:  Handb Exp Pharmacol       Date:  2013

9.  Expression of ganglioside GM3 and H-2 antigens in clones with different metastatic and growth potentials isolated from Lewis lung carcinoma (3LL) cell line.

Authors:  J Inokuchi; M Jimbo; Y Kumamoto; H Shimeno; A Nagamatsu
Journal:  Clin Exp Metastasis       Date:  1993-01       Impact factor: 5.150

Review 10.  Novel chemotherapeutic drugs in sphingolipid cancer research.

Authors:  Daniel Canals; Yusuf A Hannun
Journal:  Handb Exp Pharmacol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.